Overview

Aspirin, Heparin and Miscarriage

Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Efficacy of low dose aspirin (LDA) versus LDA plus low-molecular-weight-heparin (LMWH) in patients with a history of recurrent miscarriages.
Phase:
Phase 4
Details
Lead Sponsor:
University of Khartoum
Treatments:
Aspirin
Calcium heparin
Dalteparin
Enoxaparin
Heparin
Heparin, Low-Molecular-Weight